Stay updated on Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.

Latest updates to the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedA new revision (v3.6.4) was added to the study record history, and the previous revision (v3.6.3) was removed from the list, reflecting an update to the record's version history.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe record history now includes a newer revision (v3.6.3) replacing the previous revision (v3.6.2), indicating an update to the study record.SummaryDifference0.1%

- Check40 days agoChange DetectedFooter area expanded with additional site-wide links and policy text, representing a system-wide footer update rather than changes to the study content.SummaryDifference31%

- Check47 days agoChange DetectedThe study record history now shows two Results Submission Events instead of one, indicating an additional results submission event reflected in the history.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study record now shows that no participants are being sought, updating the recruitment status. A new revision tag, v3.6.0, has been added to the history to reflect an updated record version.SummaryDifference0.4%

- Check62 days agoChange DetectedThe record history now shows a new revision (v3.5.5) replacing the prior v3.5.4. This indicates an updated version of the study record in ClinicalTrials.gov history.SummaryDifference0.1%

Stay in the know with updates to Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.